
    
      Estimated enrollment Start: May 2013 (estimated 90 day duration) Estimated last follow-up:
      September 2013 Follow-Up Duration: Subjects in the intent-to-treat population will be
      followed from enrollment through 6 months Â±14 days for the effectiveness and safety endpoints
    
  